Evidence map›Paper›PMID 36269862›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Human neutrophil development and functionality are enabled in a humanized mouse model.

Yunjiang Zheng, Esen Sefik, John Astle, Kutay Karatepe, Hasan H Öz, Angel G Solis, Ruaidhrí Jackson, Hongbo R Luo, Emanuela M Bruscia, Stephanie Halene and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. CAR-neutrophils produced in vivo to treat glioma.Nature biomedical engineering · 2026
    Article
  9. Review
  10. Humanization of CD47 enables development of functional human neutrophils via postirradiation remodeling of the bone marrow.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Dying to Defend: Neutrophil Death Pathways and their Implications in Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Yunjiang ZhengDepartment of Immunobiology, Yale University, New Haven, CT 06520.
Esen SefikDepartment of Immunobiology, Yale University, New Haven, CT 06520.
John AstleDepartment of Immunobiology, Yale University, New Haven, CT 06520.
Kutay KaratepeDepartment of Cell Biology, Yale University, New Haven, CT 06520.
Hasan H ÖzSection of Pediatric Pulmonology, Allergy, Immunology & Sleep Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520.
Angel G SolisDepartment of Immunobiology, Yale University, New Haven, CT 06520.
Ruaidhrí JacksonDepartment of Immunobiology, Yale University, New Haven, CT 06520.
Hongbo R LuoDepartment of Laboratory Medicine, The Stem Cell Program, Boston Children's Hospital, Boston, MA 02115.
Emanuela M BrusciaSection of Pediatric Pulmonology, Allergy, Immunology & Sleep Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520.
Stephanie HaleneSection of Hematology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT 06520.
Liang ShanDepartment of Immunobiology, Yale University, New Haven, CT 06520.
Richard A FlavellDepartment of Immunobiology, Yale University, New Haven, CT 06520.
Yale University · USBoston Children's Hospital · USHarvard University · USHoward Hughes Medical Institute · USUniversity of Pennsylvania · USWashington University in St. Louis · USYale Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Novel Strategies to Improve Blood Transfusion PracticeP01HL158688 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Hongbo R Luo · 2022 to 2026
$12.9M
Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
Enhancing neutrophil function in neutropenia-related pneumoniaR01HL092020 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2009 to 2022
$5.2M
Role of Ezrin in MacrophagesR01AI153422 · NIAID · YALE UNIVERSITY · PI BRUSCIA, EMANUELA MARINA · 2021 to 2025
$3.2M
Pathogenic monocyte response to chronic lung inflammation in cystic fibrosisR01HL157776 · NHLBI · YALE UNIVERSITY · PI BRUSCIA, EMANUELA MARINA · 2022 to 2025
$3.1M
Cell-based high-throughput chemical genetic screening for GSDMD inhibitorsR01AI141386 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2019 to 2022
$1.8M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001863NHLBI NIH HHS P01 HL158688NHLBI NIH HHS R01 HL092020NHLBI NIH HHS R01 HL157776NHLBI NIH HHS T32 HL007974NIAID NIH HHS R01 AI141386NIAID NIH HHS R01 AI153422NIDDK NIH HHS P30 DK045735NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

Mice with a functional human immune system serve as an invaluable tool to study the development and function of the human immune system in vivo. A major technological limitation of all current humanized mouse models is the lack of mature and functional human neutrophils in circulation and tissues. To overcome this, we generated a humanized mouse model named MISTRGGR, in which the mouse granulocyte colony-stimulating factor (G-CSF) was replaced with human G-CSF and the mouse G-CSF receptor gene was deleted in existing MISTRG mice. By targeting the G-CSF cytokine-receptor axis, we dramatically improved the reconstitution of mature circulating and tissue-infiltrating human neutrophils in MISTRGGR mice. Moreover, these functional human neutrophils in MISTRGGR are recruited upon inflammatory and infectious challenges and help reduce bacterial burden. MISTRGGR mice represent a unique mouse model that finally permits the study of human neutrophils in health and disease.

Indexed as

NeutrophilsReceptors, Granulocyte Colony-Stimulating FactorAnimalsCytokinesGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorHumansMiceCytokinesGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorReceptors, Granulocyte Colony-Stimulating Factorbacterial infectionhumanized mouseinnate immunityneutrophils

Identifiers

PMID36269862
PMCPMC9618085
OpenAlexW4307043463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.